There is a clinical trial in phase 3 led by a researcher at Wake Forest which found earlier that participants that took a long-acting intranasal insulin demonstrated improved cognition in adults with mild cognitive impairment.
Results will be made public in 12 months. Fingers crossed for some kind of breakthrough.
MCI (mild cognitive impairment) is a neurological disorder that occurs in older adults which manifests as cognitive impairment BUT NOT impairment in activities of daily living.
First reported in J Alzheimers Dis 2015;44(30:897-906 20